Stay updated on Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.

Latest updates to the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page
- ChecktodayChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check7 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice as well as Revision: v3.4.1. These changes appear to be maintenance updates and do not alter the trial details or patient-facing information on the page.SummaryDifference0.4%

- Check44 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's current status. Updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check51 days agoChange DetectedShow glossary was added; wording tweaks include updating 'Last Update Submitted that Met QC Criteria' to proper capitalization, changing 'No FEAR Act Data' to 'No FEAR Act data', and the page footer now showing 'Revision: v3.4.0' instead of 'v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check65 days agoChange DetectedThe page shows a minor revision update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive Dosing of Ipilimumab and Nivolumab Clinical Trial page.